Showing 101 - 120 results of 169 for search '"Безопасность и риск фармакотерапии"', query time: 0.05s Refine Results
  1. 101
    SIGNAL AS A TOOL OF THE PHARMACOVIGILANCE

    SIGNAL AS A TOOL OF THE PHARMACOVIGILANCE by E. O. Zhuravleva, N. Yu. Velts, G. V. Kutekhova, M. A. Darmostukova, R. N. Alyautdin

    Published 2018-06-01
    “…Безопасность и риск фармакотерапии…”
    Get full text
    Article
    Save to List
    Saved in:
  2. 102
    Analysis of the Consumption of Medicinal Products Associated with a High Risk of Drug-Induced Liver Injury in Patients with COVID-19

    Analysis of the Consumption of Medicinal Products Associated with a High Risk of Drug-Induced Liver Injury in Patients with COVID-19 by V. I. Petrov, A. Yu. Ryazanova, N. S. Tokareva

    Published 2024-10-01
    “…Безопасность и риск фармакотерапии…”
    Get full text
    Article
    Save to List
    Saved in:
  3. 103
    Safety of Biological Medicinal Products for Hereditary Coagulopathies: An Analysis of the Russian Pharmacovigilance Database

    Safety of Biological Medicinal Products for Hereditary Coagulopathies: An Analysis of the Russian Pharmacovigilance Database by D. S. Fokina, O. V. Zhukova, A. L. Khokhlov

    Published 2025-06-01
    “…Безопасность и риск фармакотерапии…”
    Get full text
    Article
    Save to List
    Saved in:
  4. 104
    Retrospective Analysis of the Safety of Antibacterial Medicinal Products for Elderly Patients with Community-Acquired Lower Respiratory Tract Infections

    Retrospective Analysis of the Safety of Antibacterial Medicinal Products for Elderly Patients with Community-Acquired Lower Respiratory Tract Infections by G. I. Gorodetskaya, A. B. Prokofiev, S. Yu. Serebrova, E. Yu. Demchenkova, M. V. Zhuravleva, O. A. Demidova, T. V. Alexandrova, I. A. Mazerkina, E. A. Sokova, O. V. Muslimova

    Published 2023-03-01
    “…Безопасность и риск фармакотерапии…”
    Get full text
    Article
    Save to List
    Saved in:
  5. 105
    Experience in Using Antiviral Agents for the Treatment of Novel Coronavirus Infection (COVID-19) in Kyrgyzstan

    Experience in Using Antiviral Agents for the Treatment of Novel Coronavirus Infection (COVID-19) in Kyrgyzstan by A. A. Zurdinova, A. Z. Kutmanova

    Published 2021-12-01
    “…Безопасность и риск фармакотерапии…”
    Get full text
    Article
    Save to List
    Saved in:
  6. 106
    ON THE QUESTION OF THE DEVELOPMENT OF FETAL CONGENITAL MALFORMATIONS IN THE CONDITIONS OF PREVENTIVE USE BY MOTHERS OF FOLIC ACID IN THE PERINATAL PERIOD

    ON THE QUESTION OF THE DEVELOPMENT OF FETAL CONGENITAL MALFORMATIONS IN THE CONDITIONS OF PREVENTIVE USE BY MOTHERS OF FOLIC ACID IN THE PERINATAL PERIOD by I. A. Toropova, R. N. Alyautdin, O. S. Alyautdina, B. K. Romanov

    Published 2018-02-01
    “…Безопасность и риск фармакотерапии…”
    Get full text
    Article
    Save to List
    Saved in:
  7. 107
    Vladimir Chulanov: “Our experience with overcoming the pandemic will help us effectively address future threats”

    Vladimir Chulanov: “Our experience with overcoming the pandemic will help us effectively address future threats” by article Editorial

    Published 2022-12-01
    “…Безопасность и риск фармакотерапии…”
    Get full text
    Article
    Save to List
    Saved in:
  8. 108
    Anti-amyloid Monoclonal Antibodies for Alzheimer’s Disease: A New Hope? (Review)

    Anti-amyloid Monoclonal Antibodies for Alzheimer’s Disease: A New Hope? (Review) by I. A. Mazerkina

    Published 2025-04-01
    “…Безопасность и риск фармакотерапии…”
    Get full text
    Article
    Save to List
    Saved in:
  9. 109
    Vaccine Safety International Monitoring

    Vaccine Safety International Monitoring by M. A. Darmostukova, I. I. Snegireva, N. Yu. Velts, A. S. Kazakov, R. N. Alyautdin

    Published 2019-03-01
    “…Безопасность и риск фармакотерапии…”
    Get full text
    Article
    Save to List
    Saved in:
  10. 110
    Form of report on adverse drug reaction

    Form of report on adverse drug reaction by Editorial Article

    Published 2018-02-01
    “…Безопасность и риск фармакотерапии…”
    Get full text
    Article
    Save to List
    Saved in:
  11. 111
    WoE Analysis and Key Risk Factors in Preclinical Development of Medicinal Products: A Review

    WoE Analysis and Key Risk Factors in Preclinical Development of Medicinal Products: A Review by G. N. Engalycheva, R. D. Syubaev

    Published 2024-12-01
    “…Безопасность и риск фармакотерапии…”
    Get full text
    Article
    Save to List
    Saved in:
  12. 112
    ANALYSIS OF THE DECISIONS OF FOREIGN REGULATORY AUTHORITIE

    ANALYSIS OF THE DECISIONS OF FOREIGN REGULATORY AUTHORITIE by article editorial

    Published 2018-06-01
    “…Безопасность и риск фармакотерапии…”
    Get full text
    Article
    Save to List
    Saved in:
  13. 113
    Russian CIOMS-form

    Russian CIOMS-form by Editorial Article

    Published 2018-02-01
    “…Безопасность и риск фармакотерапии…”
    Get full text
    Article
    Save to List
    Saved in:
  14. 114
    INFORMATION FOR AUTHORS

    INFORMATION FOR AUTHORS by article editorial

    Published 2018-06-01
    “…Безопасность и риск фармакотерапии…”
    Get full text
    Article
    Save to List
    Saved in:
  15. 115
    Some Aspects of Drug Induced Nephrotoxicity Assessment

    Some Aspects of Drug Induced Nephrotoxicity Assessment by E. A. Sokova, V. V. Arkhipov, I. A. Mazerkina, O. V. Muslimova

    Published 2020-09-01
    “…Безопасность и риск фармакотерапии…”
    Get full text
    Article
    Save to List
    Saved in:
  16. 116
    Risk Assessment Algorithms in Pharmacovigilance: A Review

    Risk Assessment Algorithms in Pharmacovigilance: A Review by T. M. Bukatina

    Published 2025-06-01
    “…Безопасность и риск фармакотерапии…”
    Get full text
    Article
    Save to List
    Saved in:
  17. 117
    New Edition of the EAEU Good Pharmacovigilance Practice: What Has Changed?

    New Edition of the EAEU Good Pharmacovigilance Practice: What Has Changed? by D. A. Rozhdestvensky

    Published 2023-03-01
    “…Безопасность и риск фармакотерапии…”
    Get full text
    Article
    Save to List
    Saved in:
  18. 118
    ON THE SAFETY OF ANTIBACTERIAL DRUGS USED IN PEDIATRICS

    ON THE SAFETY OF ANTIBACTERIAL DRUGS USED IN PEDIATRICS by A. R. Titova, E. Y. Pasternak, I. L. Asetskaya, S. K. Zyryanov, V. A. Polivanov, R. N. Alyautdin, B. K. Romanov

    Published 2018-02-01
    “…Безопасность и риск фармакотерапии…”
    Get full text
    Article
    Save to List
    Saved in:
  19. 119
    К читателям

    К читателям by Editorial Article

    Published 2018-02-01
    “…Безопасность и риск фармакотерапии…”
    Get full text
    Article
    Save to List
    Saved in:
  20. 120
    Quantitative Signal Detection for COVID-19 Medicinal Products Based on Retrospective Analysis of Spontaneous Reports from the Russian Pharmacovigilance Database

    Quantitative Signal Detection for COVID-19 Medicinal Products Based on Retrospective Analysis of Spontaneous Reports from the Russian Pharmacovigilance Database by S. A. Mishinova, A. S. Kolbin, Yu. S. Polushin, E. V. Verbitskaya

    Published 2024-04-01
    “…Безопасность и риск фармакотерапии…”
    Get full text
    Article
    Save to List
    Saved in:

Search Tools: